期刊
SCHIZOPHRENIA BULLETIN
卷 38, 期 3, 页码 426-432出版社
OXFORD UNIV PRESS
DOI: 10.1093/schbul/sbq086
关键词
psychosis; kynurenate; olanzapine; cerebrospinal fluid; tryptophan
类别
资金
- Hallstens Forskningsstiftelse
- Swedish Brain Foundation
- Ostergotland County Council
- Svenska Lakaresallskapet
- Karolinska Institutet
- Torsten och Ragnar Soderbergs stiftelse
- Swedish Research Council [2009-3068, 2008-3822, 2009-4046, 2008-2578]
The kynurenic acid (KYNA) hypothesis for schizophrenia is partly based on studies showing increased brain levels of KYNA in patients. KYNA is an endogenous metabolite of tryptophan (TRP) produced in astrocytes and antagonizes N-methyl-D-aspartate and alpha 7* nicotinic receptors. The formation of KYNA is determined by the availability of substrate, and hence, we analyzed KYNA and its precursors, kynurenine (KYN) and TRP, in the cerebrospinal fluid (CSF) of patients with schizophrenia. CSF from male patients with schizophrenia on olanzapine treatment (n = 16) was compared with healthy male volunteers (n = 29). KYN and KYNA concentrations were higher in patients with schizophrenia (60.7 +/- 4.37nM and 2.03 +/- 0.23nM, respectively) compared with healthy volunteers (28.6 +/- 1.44nM and 1.36 +/- 0.08nM, respectively), whereas TRP did not differ between the groups. In all subjects, KYN positively correlated to KYNA. Our results demonstrate increased levels of CSF KYN and KYNA in patients with schizophrenia and further support the hypothesis that KYNA is involved in the pathophysiology of schizophrenia.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据